Etoposide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Etoposide drug offered from Mylan Pharmaceuticals Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | etoposide |
| SUBSTANCE NAME: | ETOPOSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2001-10-22 |
| END MARKETING DATE: | 0000-00-00 |
Etoposide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Etoposide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2001-10-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-3266_a91c86a3-28dc-4ffd-894d-3b7740ae4e42 |
| PRODUCT NDC: | 0378-3266 |
| APPLICATION NUMBER: | ANDA075635 |
Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers:
